Name: Gianluca Calogero Campo
Date of birth: 19 june 1978, Cervia (RA)
Italy
CONTATS:
HOUSE: via dei Morari 33, Ferrara (FE), 44123 Italy
OFFICE: U.O. Cardiologia, Azienda Ospedaliera Universitaria S.Anna, Via Aldo Moro, 8, Cona (FE), 44124 Italia
MOBILE PHONE: 349/3757919
OFFICE PHONE: 0532/237079
e-mail: cmpglc@unife.it
CURRENT POSITION:
-full professor in Cardiology (MED11), University of Ferrara,
-director school of Cardiology, University of Ferrara,
-director Interventional catheterization laboratory, Azienda Ospedaliera Universitaria di Ferrara
-director of the Clinical Research program of the Laboratorio per le Tecnologie delle Terapie Avanzate (LTTA) of the University of Ferrara.
EDUCATION:
-degree in Medicine, 110/110 cum laude, year 2003;
-degree in Cardiology, 50/50 cum laude, year 2007
PROFESSIONAL CAREER:
-assistant professor in Cardiology (MED11), University of Ferrara, from 2008 to 2015;
-associate professor in Cardiology (MED11), University of Ferrara, from 2015-2020;
-full professor in Cardiology (MED11), University of Ferrara, from 2020 to today;
-director school of Cardiology, University of Ferrara, from 2015 to today;
-member of the regional Ethic Committee Area Vasta Emilia Centro, University of Bologna, from 2015 to today;
-member of Collegio dei Docenti del Dottorato di Ricerca in Medicina Molecolare e Farmacologia, University of Ferrara, from 2016 to 2020;
-member of Collegio dei Docenti del Dottorato di Ricerca in Terapie Avanzate e Farmacologia Sperimentale, University of Ferrara, from 2020 to today;
-member of the Consiglio Direttivo del Consorzio Interuniversitario “Istituto Nazionale per le Ricerche Cardiovascolari (INRC)” from 2018 to today;
-interventional cardiologist, Cariology Unit, Azienda Ospedaliera Universitaria di Ferrara, from 2008 to today
-director Interventional catheterization laboratory, Azienda Ospedaliera Universitaria di Ferrara, from 2013 to today
-director of the second level master “Interventional cardiology & structural heart disease program”
RESEARCH ACTIVITY
The research activity of Gianluca Campo is mainly focused on ischemic heart disease and in particular on myocardial infarction. The research activity ranges from basic research (endothelial function, oxidative stress, platelet aggregation, reperfusion injury) to investigator driven monocentre and multicentre studies (myocardial infarction, drug eluting stent, fractional flow reserve, strategies of revascularization, regimen of dual antiplatelet therapy, exercise program) to sponsored multicentre trials (local principal investigator or member of steering committees). Gianluca Campo won several competitive grants from public and private companies to support hi research activities.
PARTECIPATION IN EXECUTIVE OR STEERING COMMITTES OF INTERNATIONAL STUDIES
-2013: NATIONAL COORDINATOR for Italy for the study MODIFY, EUDRACT number 2012-004779-38.
-from the 2014: member of the Scientific Board of the cardiogroup.org project.
-2015: Member of the STEERING COMMITTEE of the study BVS STRATEGY IT, NCT02601781.
-2017: Member of the International Clopidogrel Pharmacogenomics Consortium (ICPC). This collaboration is granted by the National Heart, Lung, and Blood Institute of the National Institutes of Health (Award Number U01HL105198).
-2017: Member of the EXECUTIVE COMMITTEE of the study HALE-BOPP, NCT03079739.
-2018: CHAIRMAN of the study FIRE, NCT03772743.
-2019: NATIONAL COORDINATOR for Italy for the study FAVOR III Europe-Japan, NCT03729739.
-2019: CHAIRMAN of the study PIPELINE, NCT04183465
PRINCIPAL INVESTIGATOR OF INTERNATIONAL SPONSORED STUDIES
Gianluca Campo was the Principal Investigator for the Cardiology Unit of the University Hospital of Ferrara in the following international, multicentre, sponsored clinical trials: ABSORB II (NCT01425281), MATRIX (NCT01433627), FAME II (NCT01132495), REGULATE PCI (NCT01848106), COMPLETE (NCT01740479), FAVOR II (NCT02959814), ENTRUST-AF (NCT02866175), FABOLUS FASTER (NCT02978040), XIENCE 28 (NCT03355742), PACIFIC-AMI (NCT04304534).
PRINCIPAL INVESTIGATOR OF INVESTIGATOR-DRIVEN STUDIES
Gianluca Campo ideated and conducted at the Cardiology Unit of the University Hospital of Ferrara the following investigator-driven, monocentre or multicentre, clinical trials: SCAP (NCT02324660), FRASER (NCT02386124), NATHAN NEVER (NCT02519608), BATMAN (NCT02554006), NIRVANA (NCT03216811), SHERPA-MAGIC (NCT03327961).
GRANTS
-2015: unconditioned grant from Externally Sponsored Research, Medimmune & Astrazeneca, for the study "Evaluation of effects of ticagrelor vs. clopidogrel on endothelial, platelet and inflammation parameters in patients with stable coronary artery disease and chronic obstructive pulmonary disease undergoing PCI", NCT02519608.
-2015: winner in the competitive grant application Interdisciplinary Research Projects (PRIA), University of Ferrara, for the project "New light for the heart: a new detection and data acquisition system for luminiscent probes".
-2016: unconditioned grant from the Società Italiana di Cardiologia Interventistica (GISE) for the study "Fractional Flow Reserve in Italian Cath-labs (ERIS)", NCT03082989.
-2017: unconditioned grant from Biosline SpA for the study "Nutraceutical in cardiovascular primary prevention", NCT03216811.
-2017: winner in the competitive grant application Investigator-sponsored Research Program of Boston Scientific (Europe Division) for the study "Long-term outcome of deferred lesion based on fractional flow result value (HALE-BOPP)", NCT03079739.
-2018: unconditioned grant from Sahajanand Medical Technologies (SMT) PVT. LTD., Medis Medical Imaging Systems B.V, Siemens HealthCare, GE Healthcare for the study "Functional versus Culprit-only Revascularization in Elderly Patients with Myocardial Infarction and Multivessel Disease”, NCT03772743.
-2019: winner BANDO DELLA RICERCA SANITARIA FINALIZZATA 2018, category GIOVANI RICERCATORI, CHANGE-PROMOTING with the study “effectiveness and feasibility of an early, tailored, physical activity program including supervised sessions and home-based exercises for patients with myocardial infarction aged 70 years and older” (NCT04183465).
-2020: responsible of the partner organization no. 4 (University of Ferrara) in the project “mixed reality supporting advanced medical education – a new method of teaching medical skills, winner of the ERASMUS+ call 2020 round 1 KA2 – cooperation for innovation and the exchange of good practices, KA203 – strategic partnerships for higher education.
BIBLIOMETRIC INDEXES
-From Scopus: 245 documents, 7102 citations, 40 h-index
-From Google Scholar: 10674 citations, 48 h-index, i10-index 150
Date of birth: 19 june 1978, Cervia (RA)
Italy
CONTATS:
HOUSE: via dei Morari 33, Ferrara (FE), 44123 Italy
OFFICE: U.O. Cardiologia, Azienda Ospedaliera Universitaria S.Anna, Via Aldo Moro, 8, Cona (FE), 44124 Italia
MOBILE PHONE: 349/3757919
OFFICE PHONE: 0532/237079
e-mail: cmpglc@unife.it
CURRENT POSITION:
-full professor in Cardiology (MED11), University of Ferrara,
-director school of Cardiology, University of Ferrara,
-director Interventional catheterization laboratory, Azienda Ospedaliera Universitaria di Ferrara
-director of the Clinical Research program of the Laboratorio per le Tecnologie delle Terapie Avanzate (LTTA) of the University of Ferrara.
EDUCATION:
-degree in Medicine, 110/110 cum laude, year 2003;
-degree in Cardiology, 50/50 cum laude, year 2007
PROFESSIONAL CAREER:
-assistant professor in Cardiology (MED11), University of Ferrara, from 2008 to 2015;
-associate professor in Cardiology (MED11), University of Ferrara, from 2015-2020;
-full professor in Cardiology (MED11), University of Ferrara, from 2020 to today;
-director school of Cardiology, University of Ferrara, from 2015 to today;
-member of the regional Ethic Committee Area Vasta Emilia Centro, University of Bologna, from 2015 to today;
-member of Collegio dei Docenti del Dottorato di Ricerca in Medicina Molecolare e Farmacologia, University of Ferrara, from 2016 to 2020;
-member of Collegio dei Docenti del Dottorato di Ricerca in Terapie Avanzate e Farmacologia Sperimentale, University of Ferrara, from 2020 to today;
-member of the Consiglio Direttivo del Consorzio Interuniversitario “Istituto Nazionale per le Ricerche Cardiovascolari (INRC)” from 2018 to today;
-interventional cardiologist, Cariology Unit, Azienda Ospedaliera Universitaria di Ferrara, from 2008 to today
-director Interventional catheterization laboratory, Azienda Ospedaliera Universitaria di Ferrara, from 2013 to today
-director of the second level master “Interventional cardiology & structural heart disease program”
RESEARCH ACTIVITY
The research activity of Gianluca Campo is mainly focused on ischemic heart disease and in particular on myocardial infarction. The research activity ranges from basic research (endothelial function, oxidative stress, platelet aggregation, reperfusion injury) to investigator driven monocentre and multicentre studies (myocardial infarction, drug eluting stent, fractional flow reserve, strategies of revascularization, regimen of dual antiplatelet therapy, exercise program) to sponsored multicentre trials (local principal investigator or member of steering committees). Gianluca Campo won several competitive grants from public and private companies to support hi research activities.
PARTECIPATION IN EXECUTIVE OR STEERING COMMITTES OF INTERNATIONAL STUDIES
-2013: NATIONAL COORDINATOR for Italy for the study MODIFY, EUDRACT number 2012-004779-38.
-from the 2014: member of the Scientific Board of the cardiogroup.org project.
-2015: Member of the STEERING COMMITTEE of the study BVS STRATEGY IT, NCT02601781.
-2017: Member of the International Clopidogrel Pharmacogenomics Consortium (ICPC). This collaboration is granted by the National Heart, Lung, and Blood Institute of the National Institutes of Health (Award Number U01HL105198).
-2017: Member of the EXECUTIVE COMMITTEE of the study HALE-BOPP, NCT03079739.
-2018: CHAIRMAN of the study FIRE, NCT03772743.
-2019: NATIONAL COORDINATOR for Italy for the study FAVOR III Europe-Japan, NCT03729739.
-2019: CHAIRMAN of the study PIPELINE, NCT04183465
PRINCIPAL INVESTIGATOR OF INTERNATIONAL SPONSORED STUDIES
Gianluca Campo was the Principal Investigator for the Cardiology Unit of the University Hospital of Ferrara in the following international, multicentre, sponsored clinical trials: ABSORB II (NCT01425281), MATRIX (NCT01433627), FAME II (NCT01132495), REGULATE PCI (NCT01848106), COMPLETE (NCT01740479), FAVOR II (NCT02959814), ENTRUST-AF (NCT02866175), FABOLUS FASTER (NCT02978040), XIENCE 28 (NCT03355742), PACIFIC-AMI (NCT04304534).
PRINCIPAL INVESTIGATOR OF INVESTIGATOR-DRIVEN STUDIES
Gianluca Campo ideated and conducted at the Cardiology Unit of the University Hospital of Ferrara the following investigator-driven, monocentre or multicentre, clinical trials: SCAP (NCT02324660), FRASER (NCT02386124), NATHAN NEVER (NCT02519608), BATMAN (NCT02554006), NIRVANA (NCT03216811), SHERPA-MAGIC (NCT03327961).
GRANTS
-2015: unconditioned grant from Externally Sponsored Research, Medimmune & Astrazeneca, for the study "Evaluation of effects of ticagrelor vs. clopidogrel on endothelial, platelet and inflammation parameters in patients with stable coronary artery disease and chronic obstructive pulmonary disease undergoing PCI", NCT02519608.
-2015: winner in the competitive grant application Interdisciplinary Research Projects (PRIA), University of Ferrara, for the project "New light for the heart: a new detection and data acquisition system for luminiscent probes".
-2016: unconditioned grant from the Società Italiana di Cardiologia Interventistica (GISE) for the study "Fractional Flow Reserve in Italian Cath-labs (ERIS)", NCT03082989.
-2017: unconditioned grant from Biosline SpA for the study "Nutraceutical in cardiovascular primary prevention", NCT03216811.
-2017: winner in the competitive grant application Investigator-sponsored Research Program of Boston Scientific (Europe Division) for the study "Long-term outcome of deferred lesion based on fractional flow result value (HALE-BOPP)", NCT03079739.
-2018: unconditioned grant from Sahajanand Medical Technologies (SMT) PVT. LTD., Medis Medical Imaging Systems B.V, Siemens HealthCare, GE Healthcare for the study "Functional versus Culprit-only Revascularization in Elderly Patients with Myocardial Infarction and Multivessel Disease”, NCT03772743.
-2019: winner BANDO DELLA RICERCA SANITARIA FINALIZZATA 2018, category GIOVANI RICERCATORI, CHANGE-PROMOTING with the study “effectiveness and feasibility of an early, tailored, physical activity program including supervised sessions and home-based exercises for patients with myocardial infarction aged 70 years and older” (NCT04183465).
-2020: responsible of the partner organization no. 4 (University of Ferrara) in the project “mixed reality supporting advanced medical education – a new method of teaching medical skills, winner of the ERASMUS+ call 2020 round 1 KA2 – cooperation for innovation and the exchange of good practices, KA203 – strategic partnerships for higher education.
BIBLIOMETRIC INDEXES
-From Scopus: 245 documents, 7102 citations, 40 h-index
-From Google Scholar: 10674 citations, 48 h-index, i10-index 150
